Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Three patients with malignant pheochromocytoma were treated with [131I]metaiodobenzylguanidine (131I-MIBG). In two patients with widespread metastatic disease, the effect of treatment was palliative and of short duration. In the third case, with only residual tumor and no metastases, the treatment was effective after 22 GBq of 131I-MIBG.
Schvartz
C
C
Nuclear Medicine Service, Institut Jean Godinot, Reims, France.
Gibold
C
C
Vuillemin
B
B
Delisle
M J
MJ
D019797:3-Iodobenzylguanidine; D000310:Adrenal Gland Neoplasms / Q000628:therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000627:therapeutic use*; D010673:Pheochromocytoma / Q000556:secondary / Q000628:therapy*
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine